Home

Mohammad Hirmand

CIK 1654482 · EVP and Chief Medical Officer · last filed 2026-06-15

Mohammad Hirmand is an EVP and Chief Medical Officer who has filed 17 SEC Form 4 insider transactions across 4 companies since 2015. The most recent filing, for WHWK, was dated Jun 15, 2026. Across all open-market trades the lifetime net is −$1.4M, making them a net seller over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

4

Total Filings

17

Lifetime Open-Market Net

-$1.38M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
WHWK Director — $4.47 — $0 2 2026-06-15
Whitehawk Therapeutics, Inc. (AADI) Delisted Director — $2.05 — $0 2 2024-06-14
Turning Point Therapeutics, Inc. (TPTX) Delisted EVP and Chief Medical Officer 0 $76.01 $0 -$1.26M 5 2022-08-17
MEDIVATION, INC. (MDVN) Delisted Interim Chief Medical Officer 45,583 — — -$119.1K 7 2016-09-19

Recent Filings

17 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-15 WHWK Grant (A) — $0 EDGAR
2025-06-16 WHWK Grant (A) — $0 EDGAR
2024-06-14 Whitehawk Therapeutics, Inc. (AADI) Delisted Grant (A) — $0 EDGAR
2023-03-29 Whitehawk Therapeutics, Inc. (AADI) Delisted Grant (A) — $0 EDGAR
2022-08-17 Turning Point Therapeutics, Inc. (TPTX) Delisted Disp (D) −41,284 -$3.14M EDGAR
2022-02-11 Turning Point Therapeutics, Inc. (TPTX) Delisted Mixed +33,314 -$24.3K EDGAR
2021-02-10 Turning Point Therapeutics, Inc. (TPTX) Delisted Grant (A) +6,483 $0 EDGAR
2021-01-05 Turning Point Therapeutics, Inc. (TPTX) Delisted Mixed −300 -$693.1K EDGAR
2019-12-03 Turning Point Therapeutics, Inc. (TPTX) Delisted Grant (A) — $0 EDGAR
2016-09-30 — Mixed −57,752 $0
Showing 1–10 of 17
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.